Skip to main content
OpenTrials
Completed

NCT Number: NCT00138645

The Effects of Formula Diet on Body Weight, Body Composition, and Biomarkers for Disease Compared to a Standard Diet

It is hypothesized that the use of a partial supplement diet, which includes the use of meal replacements, will result in significantly greater weight loss after three and six months compared to an isocaloric diet that does not include supplements. It is also hypothesized that the partial supplement diet will result in larger improvements in body composition, disease biomarkers, and health parameters (blood pressure, lipids) compared to the non-supplement diet. Finally, it is hypothesized that subjective ratings of satiety will be significantly higher, and ratings of hunger lower, in the group consuming a partial supplement diet.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Pennington Biomedical Research Center

Baton Rouge, Louisiana, 70808, United States

About this study

In recent decades, the prevalence of overweight and obesity has increased dramatically in developed countries. Obesity is associated with diseases such as diabetes, cardiovascular disease, hypertension, and certain cancers. Modest amounts of weight loss (e.g., 5% to 10% of initial body weight) significantly improve health and improve disease status. Recent evidence suggests that the use of supplements or meal replacements promotes greater weight loss than isocaloric food-based diets. In addition, diets that are high in protein are associated with greater ratings of satiety and reduced food intake, as well as greater weight loss, compared to lower protein diets.

The purpose of the proposed study is to test the effect of a partial supplement diet on body weight, body composition, and biomarkers for disease compared to an isocaloric diet that consists of a traditional food-based meal plan. Overweight and obese (BMI 25 to 35) participants will participate in this six-month study. The primary outcome variable is body weight loss and the secondary outcome variables include body composition, blood pressure, lipids, and subjective ratings of satiety.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female gender; of all ethnic backgrounds.
  • Healthy person who has not been diagnosed with diabetes, cardiovascular illness, renal, hepatic or other chronic diseases
  • > 17 years and < 66 years of age
  • Body mass index (BMI; kg/m2) between 25 and 35
  • For females with the potential to bear children, they meet one of the following criteria:
  • They are willing to use an acceptable method of birth control (e.g., oral contraceptive tablets, implanted contraceptive hormones, Depo-Provera® contraceptive injections, intrauterine devices, prophylactic condoms with spermicide, contraceptive diaphragms with spermicide, cervical caps with spermicide), or are in a monogamous relationship with a partner who has had a vasectomy.
  • They are sexually abstinent and intend to continue this practice, at least for the duration of the study.

Exclusion criteria

  • > 65 years and < 18 years of age
  • Regular use of medications other than birth control, vitamins or hormone replacement therapy
  • Diabetes mellitus (fasting blood sugar [FBS] > 126); persons with impaired glucose tolerance (FBS 100-125) may be admitted to the study.
  • Use of tobacco products
  • Depression or mental illness requiring treatment or medication within the last six months
  • For women, pregnancy, breast feeding, postpartum < 6 months, planning a pregnancy during the study, or are not using an acceptable method of contraception
  • Use of medications or herbal supplements that affect appetite or body weight for the previous three months
  • Patients requiring restriction of protein intake
  • Impaired kidney function (creatinine > 1.5) or liver function (liver enzymes > 3 times the upper limits of normal)

Treatment and study plan

MicroDiet

Behavioral

MicroDiet

Healthy Diet

Behavioral

Participants randomized to the Healthy Diet group will be prescribed a traditional food-based diet that contains the same number of kilocalories (1200/day) as the MicroDiet but will be instructed not to use meal replacements

Primary outcomes

  1. Body Weight Loss (kg and Percent) at Months 3 and 6

    Time frame: April 2005 to May 2006

  2. Percent Change in Body Weight (Completers).

    Time frame: 24 weeks

    Percent change in body weight from baseline to week 24(completers).

Secondary outcomes

  1. Change in Body Composition at Months 3 and 6

    Time frame: April 2005 to May 2006

  2. Disease Biomarkers (Cholesterol, Triglycerides, Etc.) at Months 3 and 6

    Time frame: April 2005 to May 2006

  3. Subjective Ratings of Appetite at Week 2 and Months 1, 2, 3, 4, 5, and 6

    Time frame: April 2005 to May 2006

Sponsors and collaborators

Lead sponsor

Pennington Biomedical Research Center

Other

Collaborators

  • Sunny Health Co., Ltd.

Registry information

Acronym: FORMULA

Important dates

Study start
2005
Primary completion
2006
Study completion
2006
First posted
Aug 30, 2005
Registry last updated
Feb 8, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.